Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects - PubMed (original) (raw)
Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects
G Boden et al. Diabetes. 2001 Jul.
Abstract
The reason for the 3- to 4-h delay between a rise in plasma free fatty acid (FFA) levels and the development of insulin resistance remains unknown. In the current study, we have tested the hypothesis that the delay may be caused by the need for plasma FFAs to first enter muscle cells and to be re-esterified there before causing insulin resistance. To this end, we have determined intramyocellular triglyceride (IMCL-TG) content with proton nuclear magnetic resonance ((1)H-NMR) spectroscopy in healthy volunteers before and 4 h after lowering of plasma FFAs (with euglycemic-hyperinsulinemic clamping) or after increasing plasma FFAs (with lipid plus heparin infusions). Increasing plasma FFAs (from 516 to 1,207 micromol/l or from 464 to 1,857 micromol/l, respectively) was associated with acute increases in IMCL-TG from 100 to 109 +/- 5% (P < 0.05) or to 133 +/- 11% (P < 0.01), respectively, and with a significant increase in insulin resistance (P < 0.05 after 3.5 h). Lowering of plasma FFAs from 560 to 41 micromol/l was associated with a tendency for IMCL-TG to decrease (from 100 to 95 +/- 3%). Changes in plasma FFAs correlated linearly with IMCL-TG (r = 0.74, P < 0.003). The demonstration that acute changes in plasma FFAs were accompanied by corresponding changes in IMCL-TG and with the development of insulin resistance, taken together with previous reports of a close correlation between IMCL-TG and insulin resistance, supported the notion that accumulation of IMCL-TG is a step in the development of FFA-induced insulin resistance.
Similar articles
- Gender factors affect fatty acids-induced insulin resistance in nonobese humans: effects of oral steroidal contraception.
Perseghin G, Scifo P, Pagliato E, Battezzati A, Benedini S, Soldini L, Testolin G, Del Maschio A, Luzi L. Perseghin G, et al. J Clin Endocrinol Metab. 2001 Jul;86(7):3188-96. doi: 10.1210/jcem.86.7.7666. J Clin Endocrinol Metab. 2001. PMID: 11443187 - Short-term suppression of plasma free fatty acids fails to improve insulin sensitivity when intramyocellular lipid is elevated.
Johnson NA, Stannard SR, Rowlands DS, Chapman PG, Thompson CH, Sachinwalla T, Thompson MW. Johnson NA, et al. Diabet Med. 2006 Oct;23(10):1061-8. doi: 10.1111/j.1464-5491.2006.01952.x. Diabet Med. 2006. PMID: 16978369 - Nicotinic acid-induced insulin resistance is related to increased circulating fatty acids and fat oxidation but not muscle lipid content.
Poynten AM, Gan SK, Kriketos AD, O'Sullivan A, Kelly JJ, Ellis BA, Chisholm DJ, Campbell LV. Poynten AM, et al. Metabolism. 2003 Jun;52(6):699-704. doi: 10.1016/s0026-0495(03)00030-1. Metabolism. 2003. PMID: 12800094 - Interaction between free fatty acids and glucose metabolism.
Boden G. Boden G. Curr Opin Clin Nutr Metab Care. 2002 Sep;5(5):545-9. doi: 10.1097/00075197-200209000-00014. Curr Opin Clin Nutr Metab Care. 2002. PMID: 12172479 Review. - [Macronutrients, fat mass, fatty acid flux and insulin sensitivity].
Ziegler O, Quilliot D, Guerci B, Drouin P. Ziegler O, et al. Diabetes Metab. 2001 Apr;27(2 Pt 2):261-70. Diabetes Metab. 2001. PMID: 11452220 Review. French.
Cited by
- Aging delays the suppression of lipolysis and fatty acid oxidation in the postprandial period.
Osmond AD, Leija RG, Arevalo JA, Curl CC, Duong JJ, Huie MJ, Masharani U, Brooks GA. Osmond AD, et al. J Appl Physiol (1985). 2024 Nov 1;137(5):1200-1219. doi: 10.1152/japplphysiol.00437.2024. Epub 2024 Sep 5. J Appl Physiol (1985). 2024. PMID: 39236144 - Metabolic Syndrome Severity Predicts Mortality in Nonalcoholic Fatty Liver Disease.
Elsaid MI, Bridges JFP, Li N, Rustgi VK. Elsaid MI, et al. Gastro Hep Adv. 2022 Apr 8;1(3):445-456. doi: 10.1016/j.gastha.2022.02.002. eCollection 2022. Gastro Hep Adv. 2022. PMID: 39131673 Free PMC article. - Metabolic responses to albumin deficiency differ distinctly between partial and full ablation of albumin expression in mice.
Abdollahi A, Szramowski M, Tomoo K, Henderson GC. Abdollahi A, et al. Lipids Health Dis. 2024 Aug 9;23(1):242. doi: 10.1186/s12944-024-02229-3. Lipids Health Dis. 2024. PMID: 39123208 Free PMC article. - GLUT4 localisation with the plasma membrane is unaffected by an increase in plasma free fatty acid availability.
Barrett JS, Strauss JA, Chow LS, Shepherd SO, Wagenmakers AJM, Wang Y. Barrett JS, et al. Lipids Health Dis. 2024 Apr 2;23(1):94. doi: 10.1186/s12944-024-02079-z. Lipids Health Dis. 2024. PMID: 38566151 Free PMC article. - The impact of metabolic syndrome severity on racial and ethnic disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Elsaid MI, Bridges JFP, Mumtaz K, Li N, Sobotka L, Rustgi VK, Paskett ED. Elsaid MI, et al. PLoS One. 2024 Mar 15;19(3):e0299836. doi: 10.1371/journal.pone.0299836. eCollection 2024. PLoS One. 2024. PMID: 38489287 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous